Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Lucas

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Circulation. Cardiovascular Interventions|November 11, 2010
A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary interventionJean-Claude Tardif, Philippe L L'Allier, Jean Grégoire, et al.
Transplantation|March 30, 2006
Prevention of chronic renal allograft rejection by SERP-1 proteinEric L R Bédard, Jifu Jiang, Jacqueline Arp, et al.
Journal for Immunotherapy of Cancer|July 26, 2024
FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcriptionXuemei Li, Lei Gao, Bofang Wang, et al.
Cardiovascular & Hematological Disorders Drug Targets|August 31, 2013
The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammationHao Chen, Jennifer A Davids, Donghang Zheng, et al.
Eneuro|November 18, 2021
Precision Mapping of Amyloid-β Binding Reveals Perisynaptic Localization and Spatially Restricted Plasticity DeficitsHannah S Actor-Engel, Samantha L Schwartz, Kevin C Crosby, et al.
Pathogens (Basel, Switzerland)|May 28, 2022
Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine-Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune DamageIsabela R Zanetti, Michelle Burgin, Liqiang Zhang, et al.
Scientific Reports|September 9, 2018
Selective Deletion of Heparan Sulfotransferase Enzyme, Ndst1, in Donor Endothelial and Myeloid Precursor Cells Significantly Decreases Acute Allograft RejectionHao Chen, Sriram Ambadapadi, Dara Wakefield, et al.
Circulation Research|August 16, 2003
Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-miceIlze Bot, Jan H von der Thüsen, Marjo M P C Donners, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infectionHao Chen, Donghang Zheng, Jeff Abbott, et al.
Advances in Experimental Medicine and Biology|January 9, 2010
The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeuticsAlexandra Lucas, Liying Liu, Erbin Dai, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Circulation. Cardiovascular Interventions|November 11, 2010
A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary interventionJean-Claude Tardif, Philippe L L'Allier, Jean Grégoire, et al.
Transplantation|March 30, 2006
Prevention of chronic renal allograft rejection by SERP-1 proteinEric L R Bédard, Jifu Jiang, Jacqueline Arp, et al.
Journal for Immunotherapy of Cancer|July 26, 2024
FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcriptionXuemei Li, Lei Gao, Bofang Wang, et al.
Cardiovascular & Hematological Disorders Drug Targets|August 31, 2013
The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammationHao Chen, Jennifer A Davids, Donghang Zheng, et al.
Eneuro|November 18, 2021
Precision Mapping of Amyloid-β Binding Reveals Perisynaptic Localization and Spatially Restricted Plasticity DeficitsHannah S Actor-Engel, Samantha L Schwartz, Kevin C Crosby, et al.
Pathogens (Basel, Switzerland)|May 28, 2022
Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine-Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune DamageIsabela R Zanetti, Michelle Burgin, Liqiang Zhang, et al.
Scientific Reports|September 9, 2018
Selective Deletion of Heparan Sulfotransferase Enzyme, Ndst1, in Donor Endothelial and Myeloid Precursor Cells Significantly Decreases Acute Allograft RejectionHao Chen, Sriram Ambadapadi, Dara Wakefield, et al.
Circulation Research|August 16, 2003
Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-miceIlze Bot, Jan H von der Thüsen, Marjo M P C Donners, et al.
Antimicrobial Agents and Chemotherapy|June 19, 2013
Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infectionHao Chen, Donghang Zheng, Jeff Abbott, et al.
Advances in Experimental Medicine and Biology|January 9, 2010
The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeuticsAlexandra Lucas, Liying Liu, Erbin Dai, et al.
Pageof 7